Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the schedule hereto:
Schedule
Product: Colazide
Active Ingredient(s): Balsalazide disodium dihydrate 750mg
Dosage Form: Modified release capsule
New Zealand Sponsor: AstraZeneca Limited
Manufacturer(s): Anabolic Inc, Irvine, California, United States of America
UCB Pharma SA, Chemin du Foriest, Braine-l'Alleud, Brussels, Belgium
Dated this 4th day of October 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).